Related Experiment Videos
Cardiomyopathy associated with amphetamine administration
Insights
Long-term high-dose dextroamphetamine use can cause cardiomyopathy, a serious heart condition. Withdrawal from the drug led to heart failure, indicating physical cardiac dependence.
Area of Science:
- Cardiology
- Toxicology
- Pathology
Background:
- Congestive heart failure (CHF) can have various causes, including coronary heart disease and valve disease.
- Idiopathic dilated cardiomyopathy presents a diagnostic challenge when no clear etiology is identified.
Observation:
- A 45-year-old woman presented with CHF without identifiable cardiac disease.
- She had a history of prolonged high-dose dextroamphetamine use.
Findings:
- Dextroamphetamine-induced cardiomyopathy was diagnosed.
- Cardiac dependence on dextroamphetamine was suggested by deterioration upon withdrawal.
- Similarities to myocarditis seen in pheochromocytoma were noted.
Implications:
- Dextroamphetamine is a potential cause of cardiomyopathy.
- Physicians should consider drug-induced cardiomyopathy in patients with unexplained heart failure.
- Further research into amphetamine's cardiotoxic mechanisms is warranted.
Abstract:
A 45-year-old woman with congestive heart failure, in whom there was no evidence of coronary heart disease, valve disease, or other demonstrable cause of heart failure, was found to have taken high doses of dextroamphetamine over a long period. Withdrawal of amphetamine resulted in deterioration, suggesting a physical cardiac dependence on the drug. The clinical and autopsy findings are presented and the similarities to the myocarditis associated with pheochromocytoma are discussed. The evidence presented suggests a causal relationship between administration of dextroamphetamine and the cardiomyopathy.